Dr. Sarah Chen

Dr. Sarah Chen is the Senior Science Editor at BioAge Insider, where she leads coverage of gene editing and epigenetic reprogramming research. With over 12 years of experience in science journalism, Sarah has covered breakthrough discoveries from leading institutions including the Broad Institute, Salk Institute, and Altos Labs. Before joining BioAge Insider, Sarah was a science writer at Nature Biotechnology and contributed to STAT News and MIT Technology Review. Her academic background includes postdoctoral research in epigenetics at Stanford University, where she studied cellular reprogramming mechanisms. Sarah is passionate about making complex scientific concepts accessible to general audiences while maintaining scientific rigor. Her work has been cited in discussions about the ethical implications of longevity research and regenerative medicine.